Moreover, the role of immunity in PDAC remains unclear; the B- and T cells of PDAC patients can be induced to recognize some tumor-associated antigens, such as Wilms’ tumor gene 1 (WT1), mucin 1 (MUC1), human telomerase reverse transcriptase (hTERT), mutated K-RAS, and carcinoembryonic antigen (CEA). Here, MUC1 is linked to neoplasm.